ABSTRACT

Congressional Budget Office Cost Estimate: S. 1416, Affordable Prescriptions for Patients Act of 2019   [open pdf - 82KB]

This is the Congressional Budget Office Cost Estimate for S. 1416. According to the report, "Estimated budgetary effects would stem from [1] Generic or biosimilar drugs entering the market earlier, on average, than would be the case under current law, resulting in lower federal spending for prescription drugs and subsidies for health insurance."

Publisher:
Date:
2019-07-19
Copyright:
Public Domain
Retrieved From:
Congressional Budget Office: http://www.cbo.gov/
Format:
pdf
Media Type:
application/pdf
URL:
Help with citations